Influenza and COPD Mortality Protection as Pleiotropic, Dose-Dependent Effects of Statins
- 1 April 2007
- journal article
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 131 (4), 1006-1012
- https://doi.org/10.1378/chest.06-1997
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Pandemic Influenza: A Potential Role for Statins in Treatment and ProphylaxisClinical Infectious Diseases, 2006
- Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary DiseaseJournal of the American College of Cardiology, 2006
- C-reactive protein levels and clinically important predictive outcomes in stable COPD patientsEuropean Respiratory Journal, 2006
- FactSheet: Avian influenza ('bird flu')New South Wales Public Health Bulletin, 2006
- Should Treatment of Sepsis Include Statins?Circulation, 2005
- Hypothesis: Does COPD have an autoimmune component?Thorax, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- The Effect of Statins on Mortality in Patients with BacteremiaClinical Infectious Diseases, 2001
- New Evidence for Beneficial Effects of Statins Unrelated to Lipid LoweringArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987